Enabling Broader Adoption Of Process Intensification In Biopharma
By Ganesh Kumar, Sartorius
![PI Clean PI Clean](https://vertassets.blob.core.windows.net/image/7af65698/7af65698-d0f3-492f-9dc9-da0975d8c2ed/375_250-pi_clean.png)
PI is becoming increasingly well-understood and its utility is continuously evolving to meet specific manufacturer needs, from product development to manufacturing, whether approached stepwise or end-to-end.
The benefits of process intensification (PI) in biopharmaceutical manufacturing are well established: PI enables manufacturers to increase volumetric productivity, reduce timelines, decrease facility footprint, lower costs, or improve flexibility. However, knowledge about PI implementation — from the costs to the technological and regulatory aspects, and risk mitigation — is less ubiquitous.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.